BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) fell 1.5% during trading on Friday . The company traded as low as $0.91 and last traded at $0.92. 28,858 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 111,444 shares. The stock had previously closed at $0.93.
BiomX Stock Down 1.5 %
The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 1.75. The firm has a market capitalization of $16.44 million, a P/E ratio of -1.51 and a beta of 1.30.
BiomX (NYSEAMERICAN:PHGE – Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of ($1.20) by $1.90. On average, research analysts predict that BiomX Inc. will post -2.7 EPS for the current year.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Articles
- Five stocks we like better than BiomX
- Differences Between Momentum Investing and Long Term Investing
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- What Investors Need to Know to Beat the Market
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
